Political parties in Belgium agreed Friday to form a new government, ending almost eight months of negotiations.
This followed the election victory of Flemish nationalist party N-VA, the leader of which, Bart De Wever, is set to become prime minister, heading a five-party coalition.
From a pharma perspective, this change is happening at an already key moment for the industry, as the European Commission has just published the ‘competitiveness compass’, which aims to respond to the decline in European competitiveness in a geopolitically tense environment.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze